Araceli Biosciences

📍 Portland, United States👥 40 employees💰 Last funded Feb 2023
Blending technology and science, we develop instrumentation to improve outcomes. Araceli Biosciences delivers high-performance scientific tools for tissue and cell-based biomarker discovery, drug discovery and drug development. With decades of combined biomedical research and instrument design experience, we are focused on developing scientific instrumentation to improve outcomes and enable our customers to advance scientific and medical research. Speed is essential for furthering our understanding of biology, and we believe in reducing the time needed to acquire high-quality data and obtain clear, high-quality results. By making advanced technologies accessible, we allow researchers to focus on the science, not the tool. Our goal is to develop innovative products that accelerate basic research, drug discovery, and manufacturing to advance healthy outcomes. We believe in blurring the line between science and technology, using one to improve the other in a holistic approach. We strive to make the drug discovery process more efficient, reducing the time and bandwidth needed to screen compounds. By pairing fast, easy to use hardware with advanced artificial intelligence analysis algorithms, we aim to transform the drug discovery pipeline, allowing customers to fail faster.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Araceli Biosciences?
Araceli Biosciences has 1 investors on record on gritt.io.
When did Araceli Biosciences last raise funding?
The most recent investment in Araceli Biosciences recorded on gritt.io was in February 2023.
What industry is Araceli Biosciences in?
Araceli Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Araceli Biosciences based?
Araceli Biosciences is headquartered in Portland, United States.